Akamai (AKAM) CTO Sells 3,000 Shares at $77 Under 10b5-1 Plan

Robert Blumofe, Chief Technology Officer at Akamai Technologies (AKAM), reported an insider sale on Form 4.

Accepted by SEC EDGAR 08/22/2025 - 04:34 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Robert Blumofe, Chief Technology Officer at Akamai Technologies (AKAM), reported an insider sale on Form 4. On 08/22/2025 he disposed of 3,000 shares of Akamai common stock at a price of $77 per share. Following the reported transaction he is shown as beneficially owning 27,910 shares directly. The filing also records an indirect interest described as "64.184(2) I By 401(k) Plan" with a date of record as of August 21, 2025. The sale was made under a Rule 10b5-1 trading plan adopted by Dr. Blumofe on March 12, 2025. The Form 4 was signed by Thomas M. Lair as attorney-in-fact on 08/22/2025.

Positive

• Sale executed under a Rule 10b5-1 plan, indicating a pre-established trading arrangement
• Timely and specific disclosure of the transaction on Form 4 with transaction date and price
• Reporting includes post-transaction beneficial ownership (27,910 shares directly)

Negative

• Insider disposed of 3,000 shares, which reduces the reporting person's direct stake
• Indirect interest described ambiguously as "64.184(2) I By 401(k) Plan" without clearer numeric formatting

Insights

Securities Analyst

TL;DR: A small, disclosed insider sale executed under a 10b5-1 plan; no additional material information disclosed.

The filing records a single sale of 3,000 Akamai shares at $77 each by the Chief Technology Officer under a Rule 10b5-1 plan adopted March 12, 2025. The report shows 27,910 shares beneficially owned following the transaction and references an indirect 401(k) interest as of August 21, 2025. The disclosure is routine and provides required transparency on insider activity. No other transactions, option exercises, or compensatory grants are reported in this Form 4.

Corporate Governance Expert

TL;DR: Proper procedural disclosure of insider sale under a pre-established trading plan; signature framed by power of attorney.

The Form 4 documents compliance with Section 16 reporting for an officer-level insider. The sale was executed pursuant to a 10b5-1 plan, which the filer adopted on March 12, 2025, and the filing bears a signature by an appointed power of attorney dated August 22, 2025. The Form contains the required explanatory remark noting the plan and the record date for the 401(k) interest. The filing appears complete for the transactions it reports.

Insider Trade Summary

Net Seller: 3,000 shares

Net Sell 1 txn

Insider Blumofe Robert

Role Chief Technology Officer

Sold 3,000 shs ($231K)

Share of Position Sold 9.7%

Type	Security	Shares	Price	Value
Sale	Common Stock	3,000	$77.00	$231K
Holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 27,910 shares (Direct); Common Stock — 64.184 shares (Indirect, By 401(k) Plan)

Holdings Before and After: Common Stock, 30,910 to 27,910 shares (Direct)

Other Insiders: 1 other insider reported open-market sales of this stock in the 30 days up to this filing.

Footnotes (2)

1. F1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.
2. F2. As of August 21, 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did AKAM insider Robert Blumofe sell according to the Form 4?

He sold 3,000 shares of Akamai common stock on 08/22/2025 at a price of $77 per share.

Was the sale part of a Rule 10b5-1 trading plan for AKAM insider filings?

Yes. The Form 4 states the sale was made pursuant to a Rule 10b5-1 plan adopted on March 12, 2025.

How many shares did the reporting person own after the transaction?

The Form 4 reports 27,910 shares beneficially owned following the reported transaction.

Is there any indirect ownership disclosed in the Form 4 for AKAM?

Yes. The filing lists an indirect interest noted as "64.184(2) I By 401(k) Plan" with the date referenced as August 21, 2025.

Who signed the Form 4 filing for Robert Blumofe?

The form is signed by Thomas M. Lair, as power of attorney, dated 08/22/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blumofe Robert

(Last) (First) (Middle)

C/O AKAMAI TECHNOLOGIES, INC.

145 BROADWAY

(Street)

CAMBRIDGE MA 02142

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
AKAMAI TECHNOLOGIES INC [ AKAM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Technology Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/22/2025		S(1)		3,000	D	$77	27,910	D
Common Stock								64.184(2)	I	By 401(k) Plan

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Sale was made pursuant to a Rule 10b5-1 Plan adopted by Dr. Blumofe on March 12, 2025.

2. As of August 21, 2025.

Remarks:

	/s/ Thomas M. Lair, as power of attorney	08/22/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.